Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
7,897.50
+48.10
(+0.61%)
ASX 200
7,629.00
+42.00
(+0.55%)
AUD/USD
0.6612
+0.0040
(+0.61%)
OIL
77.99
-0.96
(-1.22%)
GOLD
2,310.10
+0.50
(+0.02%)
Bitcoin AUD
96,673.69
+1,180.73
(+1.24%)
Iovance Biotherapeutics, Inc. (IOVA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
13.63
+0.75
(+5.82%)
At close: 04:00PM EDT
13.69
+0.06
(+0.44%)
After hours:
07:55PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,189
1,189
0
0
0
Cost of revenue
10,755
10,755
0
0
-
Gross profit
-9,566
-9,566
0
0
-
Operating expenses
Research development
344,077
344,077
294,781
259,039
201,727
Selling general and administrative
106,916
106,916
104,097
83,664
60,210
Total operating expenses
450,993
450,993
398,878
342,703
261,937
Operating income or loss
-460,559
-460,559
-398,878
-342,703
-261,937
Income before tax
-447,516
-447,516
-395,893
-342,252
-259,581
Income tax expense
-3,479
-3,479
0
0
-
Income from continuing operations
-444,037
-444,037
-395,893
-342,252
-259,581
Net income
-444,037
-444,037
-395,893
-342,252
-259,581
Net income available to common shareholders
-444,037
-444,037
-395,893
-342,252
-259,581
Basic EPS
-2.08
-1.89
-2.49
-2.23
-1.88
Diluted EPS
-2.08
-1.89
-2.49
-2.23
-1.88
Basic average shares
212,292
235,131
159,259
153,406
138,301
Diluted average shares
212,292
235,131
159,259
153,406
138,301
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.